Argent Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18M | Buy |
56,848
+1,971
| +4% | +$75.7K | 0.67% | 40 |
|
|
2025
Q1 | $2.13M | Buy |
54,877
+22,220
| +68% | +$861K | 0.71% | 39 |
|
|
2024
Q4 | $1.1M | Buy |
32,657
+2,847
| +10% | +$96.3K | 0.41% | 70 |
|
|
2024
Q3 | $1.22M | Buy |
29,810
+1,651
| +6% | +$67.5K | 0.45% | 62 |
|
|
2024
Q2 | $1.08M | Buy |
28,159
+2,529
| +10% | +$97.4K | 0.43% | 66 |
|
|
2024
Q1 | $1.1M | Buy |
25,630
+2,041
| +9% | +$87.5K | 0.43% | 59 |
|
|
2023
Q4 | $874K | Buy |
+23,589
| New | +$874K | 0.38% | 67 |
|
|
2021
Q3 | – | Sell |
-9,062
| Closed | -$451K | – | 135 |
|
|
2021
Q2 | $451K | Sell |
9,062
-48
| -0.5% | -$2.39K | 0.27% | 88 |
|
|
2021
Q1 | $406K | Buy |
9,110
+72
| +0.8% | +$3.21K | 0.26% | 93 |
|
|
2020
Q4 | $416K | Sell |
9,038
-300
| -3% | -$13.8K | 0.25% | 98 |
|
|
2020
Q3 | $439K | Buy |
9,338
+360
| +4% | +$16.9K | 0.3% | 86 |
|
|
2020
Q2 | $457K | Sell |
8,978
-1,803
| -17% | -$91.8K | 0.35% | 76 |
|
|
2020
Q1 | $511K | Sell |
10,781
-887
| -8% | -$42K | 0.51% | 55 |
|
|
2019
Q4 | $689K | Buy |
+11,668
| New | +$689K | 0.52% | 43 |
|